How the answers frame CeraVe
PeakMetrics asked 250 benchmark questions that never named a brand, across ChatGPT, Claude, Gemini, Perplexity and Grok, on 2026-09-29. That produced 1,250 answers. CeraVe was named in 165 of them. Grok named it most often (52 of 250) and Perplexity least (22 of 250).
The questions where CeraVe surfaced most were about product efficacy (39% visibility), trust (27%), value (23%) and ingredient transparency (20%). It barely registered on innovation (0%), employer (1%), sustainability (1%), service (2%) or shopping experience (2%). In this snapshot, CeraVe is a product-performance and price story, not a corporate one.
The sampled answers show the pattern. Claude's answer on drugstore brands that deliver consistent results grouped CeraVe with La Roche-Posay and The Ordinary around proven ingredients. Gemini's answer to the same question called CeraVe a "gold standard" for basic skincare. On sensitive skin and severe contact dermatitis, Claude and Gemini both listed CeraVe next to Vanicream and La Roche-Posay, with the ceramide and skin-barrier angle repeated.
Price shaped several answers. ChatGPT built a sub-$50 college-student routine mostly from CeraVe products and cited cerave.com for prices that summed to $42.97. Perplexity put CeraVe first among value options for dry, aging skin on a fixed income, alongside Nivea and Olay. Claude's retinol answer called the CeraVe Skin Renewing Retinol Serum a "budget-friendly pick." The credited-for tags are small and mixed: Price & Value (4) and Not Substantive (7).
In some answers CeraVe is a supporting name. Claude's entry-level marketing answer listed it as a L'Oréal brand. In the Grok answers on investor reputation and contamination lawsuits, CeraVe was named among many brands, but the supplied text leads with other companies. These answers do not tie CeraVe to an investor or litigation story.
Widely regarded as a gold standard for basic, essential skincare.
What the press is saying
PeakMetrics' news index shows 861 mentions of CeraVe in the last 30 days. In 73 of them the brand is in the headline. The recent headlines follow two storylines.
The first is a launch: a new Super Boost serum described as taking a "skin-barrier first approach to aging," syndicated across several regional and trade outlets. The second is consumer comparison and market expansion, such as a CeraVe vs. RoC cleanser piece and a report of CeraVe and La Roche-Posay entering Pakistan through authorised distribution.
CeraVe is especially popular among those with barrier disorders or extremely sensitive skin.
The gap
The two stories overlap on the skin barrier. The press headlines lean on it for the new serum, and the assistants lean on ceramides and barrier repair to explain CeraVe's place in sensitive-skin answers. The launch itself does not show up in the answers, which reflect innovation at 0% visibility.
The bigger difference is scale. CeraVe ranked fifth among the 15 beauty peers in answer appearances (165), ahead of e.l.f. Beauty (111), Neutrogena (92) and Clinique (83). Its news volume of 861 is below Clinique (1,733), Olay (1,502) and e.l.f. Beauty (1,977), and roughly in line with Neutrogena (948), whose answer count is about half of CeraVe's. Sephora, Ulta Beauty and L'Oréal lead both counts by wide margins. On this snapshot, CeraVe's presence in AI answers is larger than its press footprint would suggest.
What to watch
For a comms team, the takeaway is that the assistants describe CeraVe through efficacy, sensitive-skin suitability and price, and that description draws on sources other than the launch coverage. In the ChatGPT answer, the brand's own site was among the cited pages. Which third-party sources carry the "dermatologist" and "budget" framing is worth tracing.
The near-zero visibility on innovation, sustainability and employer questions is where the assistants had little to say about CeraVe. If the serum launch is meant to shift that, these answers offer no sign of it yet.
This is one run of live answers on one date. Model answers vary between runs, so treat the figures as a snapshot rather than a ranking or a trend.